Lantheus says CMS grants transitional pass-through reimbursement status for PYLARIFY TruVu effective Oct. 1

By Public Technologies
  • CMS granted Transitional Pass-Through payment status for PYLARIFY TruVu, effective Oct. 1, 2026.
  • Status enables separate Medicare reimbursement for the product in the hospital outpatient setting, supporting access and billing certainty.
  • CMS also assigned a permanent HCPCS code effective Oct. 1, 2026, facilitating provider billing and reimbursement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantheus Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609300830PRIMZONEFULLFEED9836896) on September 30, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk